Saavedra, Sharon .
HRN: 22-75-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2023
CEFUROXIME 500MG (TAB)
03/20/2023
03/27/2023
PO
500mg Tab
BID
Post NSVD With RMLE And Repair; Thickly Meconium Stained
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes